Variant · Snv
FGFR3 G380R
CI-VAR-00001729Explore in graph →NP_000133.1:p.Gly380ArgNM_000142.5:c.1138G>CClinVar 16328 CIViC 2405
Curated evidence
Evidence by cancer (9 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 12461689
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Malignant Bladder Neoplasm1 | ||||||||
| FGFR3 G380R | (oncogenic) | Oncogenic | C | Supports Oncogenicity | 1 | accepted | EID10490Targeted mutation analysis on the FGFR3 gene in 297 bladder cancer patients was conducted, where 177 patients were found to harbor FGFR3 mutations. One patient was found to harbor a novel G380R mutati… (full text at CIViC) PMID 12461689 · van Rhijn et al., 2002 · Open in CIViC | civic |
| Malignant Neoplasm1 | ||||||||
| FGFR3 G380R | (oncogenic) | Oncogenic | D | Supports Oncogenicity | 3 | accepted | EID12847The transmembrane domain mutation G380R was tested in a series of assays for an evaluation of oncogenicity. G380R was stably transfected into 3T3 cells along with WT controls. TAS (Transformation Ac… (full text at CIViC) PMID 34272467 · | |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available